Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of EMD 387008 vs placebo and metformin in type 2 diabetes mellitus
2006-002902-74Phase 2Completed
- Sponsor
- Merck Santé
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of imeglimin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Merck Santé. Primary endpoint: Meal test AUC glucose at specified time points. Started Aug 2006; status: completed.
02
Drugs
imeglimin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002902-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002902-74.